Impact of an ivermectin mass drug administration program against endemic scabies and strongyloidiasis

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/605804

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Overseas studies suggest sustainable and long term benefits can be obtained through the use of ivermectin in mass drug administration programs to control parasitic infections. Our study will be a critical first step in establishing if such a program can be successful in a remote Indigenous community setting, where the disease burden from scabies and strongyloidiasis (threadworm infections) is very high.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $1,289,786.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Epidemiology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Community wide mass drug administration with ivermectin | Indigenous Health | Infectious Disease | Intervention | Ivermectin mass drug administration | PGP3 | Parasites | Scabies prevalence and intensity | Strongyloides serology and clinical symptoms

Related Links